War Chest For Opponents Of Drug Cost Initiative Nearly 10 Times That Of Supporters
Those fighting against a ballot measure to impose limits on how much drugmakers can charge state agencies for prescription drugs have almost $66 million as of June 30.
Los Angeles Times:
Nearly $66 Million In Campaign Cash To Kill A Prescription Drug Ballot Measure In November
Opponents of a ballot measure that would limit how much pharmaceutical companies can charge state agencies for prescription drugs had nearly $66 million on hand in June. The campaign against Proposition 61 reported Monday it had $65.9 million in cash as of June 30. That far outpaced supporters of the measure, whose own campaign filing reported a little more than $7 million. Proposition 61 would prevent state agencies from paying more for a drug than the price paid by the U.S. Department of Veterans Affairs. Drug manufacturers, including Merck, Pfizer and AbbVie, are among the largest funders of the opposition campaign. (Bollag, 8/1)